Abstract
Retrovirus integration into the host cell genome occurs most efficiently in replicating cells. In agreement with this notion, it was observed that the efficiency with which hemopoietic stem cells (HSC) can be transduced is greatly enhanced when the hemopoietic growth factor (HGF) interleukin 3 (IL-3) is added to co-cultures of bone marrow cells with retrovirus-producing cells. The HGF IL-6, which enhances the IL-3-induced formation of blast cell colonies in vitro, is also believed to improve the transduction of HSC. Because IL-6 can be produced by a number of different cell types, we investigated whether IL-6 was present in the culture supernatant of retrovirus packaging cells and bone marrow cells. We found that the six retrovirus packaging cells tested produce large amounts of IL-6. Bone marrow cells cultured with IL-1α and IL-3 also make IL-6, and, following co-cultivation of both cell types, the concentration of IL-6 in the medium is even up to 10-fold higher than the sum of the concentrations obtained when both are cultured separately. Considering that IL-6 is produced in large amounts during co-cultivations, we believe that its effect on the transduction of HSC cannot be measured by adding extra growth factor to the co-culture medium.
Overview summary
A major goal of investigators at present is to increase the efficiency of gene transfer into murine hematopoietic pluripotent stem cells as a step toward human gene therapy via bone marrow. The optimization of the growth medium by addition of the appropriate growth factors is one of the important variables in this process. Einerhand et al. evaluate the influence of several of the critical growth factors.
Get full access to this article
View all access options for this article.
